NCT02100852
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
- TG Therapeutics Investigational Trial Site Memphis, Tennessee, United States